We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,037 results
  1. Is lysosomal acid lipase activity associated with the presence and severity of coronary artery disease?

    Background

    Lipid metabolism is considerably complex and there can be many critical steps in atherogenesis. The association between lysosomal acid...

    Emrullah Kızıltunç, Sabire Gökalp, ... Adnan Abacı in Herz
    Article 01 August 2023
  2. Androgens exacerbate hepatic triglyceride accumulation in rats with polycystic ovary syndrome by downregulating MTTP expression

    Purpose

    Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder, which is closely associated with insulin resistance, glucose and...

    Dongxu Wang, Han Zhao, ... Bing He in Endocrine
    Article 11 November 2023
  3. Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease

    Background

    Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive lipid accumulation in the liver. Riboflavin, one of water soluble...

    Yanxian Wang, **angyu Bian, ... Changjiang Guo in Nutrition & Metabolism
    Article Open access 02 January 2024
  4. Gallic acid rescues uranyl acetate induced-hepatic dysfunction in rats by its antioxidant and cytoprotective potentials

    Background

    The liver was identified as a primary target organ for the chemo-radiological effects of uranyl acetate (UA). Although the anti-oxidant and...

    Ibtisam M. H. Elmileegy, Hanan S. A. Waly, ... Eman A. Negm in BMC Complementary Medicine and Therapies
    Article Open access 22 November 2023
  5. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease

    Background and purpose

    Alcoholic liver disease (ALD), a metabolic liver disease caused by excessive alcohol consumption, has attracted increasing...

    Lin Li, Lina Kong, ... Qiang Meng in Hepatology International
    Article 06 January 2024
  6. Endocrine, metabolic, and hepatic dysfunction in patients with COVID-19 pneumonia with severe and critically ill status

    Background

    Management of endocrine and hepatic disorders is very important for better management of patient with COVID-19 infections. Hepatic and...

    Article Open access 10 March 2022
  7. Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

    Background and Objective

    Tirzepatide, a novel, once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...

    Shweta Urva, Tonya Quinlan, ... Charles T. Benson in Clinical Pharmacokinetics
    Article Open access 08 June 2022
  8. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study

    Background

    The present study investigates if common missense functional variants p.I148M and p.E167K in PNPLA3 and TM6SF2 genes, respectively,...

    Bisma Rauff, Badr Alzahrani, ... Ali Amar in BMC Gastroenterology
    Article Open access 26 August 2022
  9. Renal and hepatic dysfunction parameters correlate positively with gender among patients with recurrent malaria cases in Birnin Kebbi, Northwest Nigeria

    Background

    Simultaneous increase in transaminases and bilirubin is an indicator of hepatic dysfunction in malaria. Malaria-induced hyperbilirubinemia...

    Rotimi Johnson Ojo, Isaac Gladson Jonathan, ... Ishaya Yohanna Longdet in The Egyptian Journal of Internal Medicine
    Article Open access 22 October 2022
  10. Renal–hepatic–pancreatic dysplasia-1 with a novel NPHP3 genotype: a case report and review of the literature

    Background

    Renal–hepatic–pancreatic dysplasia type 1 (RHPD1) is a rare sporadic and autosomal recessive disorder with unknown incidence. RHPD1 is...

    Hui Zhu, Zhi-hui Zhao, ... ** Wang in BMC Pediatrics
    Article Open access 18 October 2022
  11. Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study

    Background

    Tissue-specific insulin resistance (IR) predominantly in muscle (muscle IR) or liver (liver IR) has previously been linked to distinct...

    Anouk Gijbels, Balázs Erdős, ... Lydia A. Afman in Cardiovascular Diabetology
    Article Open access 16 March 2024
  12. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice

    Aims/hypothesis

    Hyperglucagonaemia-stimulated hepatic glucose production (HGP) contributes to hyperglycaemia during type 2 diabetes. A better...

    Wanbao Yang, Wang Liao, ... Shaodong Guo in Diabetologia
    Article 19 May 2023
  13. Potential antioxidant properties and anti-diabetic and hepatic/pancreatic protective effects of dietary Boswellia serrata gum resin powder against oxidative damage in streptozotocin‐induced diabetic rats

    The present study was designed to explore the potential antidiabetic and antioxidant capacity and hepatic/pancreatic protective effects of Boswellia...

    Amel Kherouf, Ouassila Aouacheri, ... Saad Saka in Comparative Clinical Pathology
    Article 21 October 2021
  14. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

    Bile acids (BAs) can regulate their own metabolism and transport as well as other key aspects of metabolic homeostasis via dedicated (nuclear and G...

    Claudia D. Fuchs, Michael Trauner in Nature Reviews Gastroenterology & Hepatology
    Article 14 February 2022
  15. Sex-specific alterations in hepatic cholesterol metabolism in low birth weight adult guinea pigs

    Background

    Intrauterine growth restriction and low birth weight (LBW) have been widely reported as an independent risk factor for adult...

    Ousseynou Sarr, Katherine E. Mathers, ... Timothy R. H. Regnault in Pediatric Research
    Article 06 July 2021
  16. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats

    Background

    Nonalcoholic fatty liver disease (NAFLD) is considered the hepatic component of metabolic syndrome and has attracted widespread attention...

    Chenwei Song, Wei Lv, ... Lihua Song in Nutrition & Metabolism
    Article Open access 18 December 2021
  17. Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment

    Purpose

    The purpose of this study is to characterize niraparib pharmacokinetics (PK) and safety in patients with normal hepatic function (NHF) versus...

    Mehmet Akce, Anthony El-Khoueiry, ... Cindy L. O’Bryant in Cancer Chemotherapy and Pharmacology
    Article Open access 29 July 2021
  18. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives

    Acute hepatic porphyrias (AHPs) are a family of four rare genetic diseases resulting from a deficiency in one of the enzymes involved in heme...

    Matteo Marcacci, Andrea Ricci, ... Paolo Ventura in Orphanet Journal of Rare Diseases
    Article Open access 07 April 2022
  19. Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease

    The liver is often thought of as a single functional unit, but both its structural and functional architecture make it highly multivalent and...

    Philippe Lefebvre, Bart Staels in Nature Reviews Endocrinology
    Article 20 August 2021
Did you find what you were looking for? Share feedback.